125 related articles for article (PubMed ID: 31686415)
1. GLUT 1 expression is a supportive mean in predicting prognosis and survival estimates of endometrial carcinoma.
Khabaz MN; Qureshi IA; Al-Maghrabi JA
Ginekol Pol; 2019; 90(10):582-588. PubMed ID: 31686415
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Al-Maghrabi J; Abdelrahman AS; Ghabrah T; Butt NS; Al-Maghrabi B; Khabaz MN
Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
[TBL] [Abstract][Full Text] [Related]
4. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
5. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
[TBL] [Abstract][Full Text] [Related]
6. Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer.
Al-Maghrabi JA; Qureshi IA; Khabaz MN
Int J Clin Exp Pathol; 2019; 12(8):3049-3057. PubMed ID: 31934144
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
Sebastiani V; Visca P; Botti C; Santeusanio G; Galati GM; Piccini V; Capezzone de Joannon B; Di Tondo U; Alo PL
Gynecol Oncol; 2004 Jan; 92(1):101-5. PubMed ID: 14751145
[TBL] [Abstract][Full Text] [Related]
8. [Expression of glucose transporter-1 and its correlation with basic fibroblast growth factor and proliferating cell nuclear antigen in epithelial ovarian neoplasm].
Zhao SJ; Liu JY; Ren FR; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):264-8. PubMed ID: 15924676
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma.
Du MJ; Shen Q; Yin H; Rao Q; Zhou MX
Pathol Res Pract; 2016 Nov; 212(11):1048-1051. PubMed ID: 27688088
[TBL] [Abstract][Full Text] [Related]
10. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
12. Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival.
Geisler JP; Geisler HE; Manahan KJ; Miller GA; Wiemann MC; Zhou Z; Crabtree W
Int J Gynecol Cancer; 2004; 14(1):133-7. PubMed ID: 14764041
[TBL] [Abstract][Full Text] [Related]
13. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.
Ayala FR; Rocha RM; Carvalho KC; Carvalho AL; da Cunha IW; Lourenço SV; Soares FA
Molecules; 2010 Apr; 15(4):2374-87. PubMed ID: 20428049
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma.
Hanbazazh M; Samman A; Samargandy S; Al-Maghrabi J
Libyan J Med; 2023 Dec; 18(1):2283953. PubMed ID: 37988377
[TBL] [Abstract][Full Text] [Related]
15. Increased osteopontin expression in endometrial carcinoma is associated with better survival outcome.
Al Maghrabi H; Gomaa W; Al-Maghrabi J
Ginekol Pol; 2020; 91(2):73-78. PubMed ID: 32141052
[TBL] [Abstract][Full Text] [Related]
16. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
Alkushi A; Lim P; Coldman A; Huntsman D; Miller D; Gilks CB
Int J Gynecol Pathol; 2004 Apr; 23(2):129-37. PubMed ID: 15084841
[TBL] [Abstract][Full Text] [Related]
19. Clusterin immunoexpression is associated with early stage endometrial carcinomas.
Al-Maghrabi JA; Butt NS; Anfinan N; Sait K; Sait H; Bajouh O; Khabaz MN
Acta Histochem; 2016 May; 118(4):430-4. PubMed ID: 27079858
[TBL] [Abstract][Full Text] [Related]
20. The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Baschnagel AM; Wobb JL; Dilworth JT; Williams L; Eskandari M; Wu D; Pruetz BL; Wilson GD
Radiother Oncol; 2015 Oct; 117(1):118-24. PubMed ID: 26328941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]